BlackRock Raises Stakes in ZTE and Jiangsu Hengrui H-Shares, HKEX Filings Show
HKEX filings show BlackRock's long position in ZTE H-shares rose to 7.30% and in Jiangsu Hengrui H-shares to 6.51% as of October 29.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Disclosures published on the Hong Kong Exchange (HKEX) show that BlackRock lifted its long position in H-shares of China's ZTE Corp to 7.30% on October 29, up from 6.79%. A separate notice shows its stake in H-shares of Jiangsu Hengrui Pharmaceuticals rose to 6.51% from 5.89%.
Both filings cover long positions, meaning holdings that gain when share prices rise, and reflect the position at the close of October 29. Reuters also reported the Hengrui disclosure, citing HKEX.
why it matters
Filings like these are routine information about shareholding structures. They show a large institutional investor building exposure to Chinese companies listed in Hong Kong, but on their own they rarely move share prices.
tags
instruments
sources
- Blackrock's Long Position In H-Shares Of ZTE Increases To 7.30% On Oct 29 From 6.79% — HKEX, 3 November 2026 at 10:30 UTC
- Blackrock's Long Position In H-Shares Of Jiangsu Hengrui Pharmaceuticals Increases To 6.51% On Oct 29, HKEX Says — Reuters, 3 November 2026 at 10:29 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗